Key result
Calmodulin variants N97I and Q135P associated with congenital arrhythmia impair the kinetic discrimination and allosteric communication required for selective recognition of ryanodine receptors.
Why the study?
The molecular mechanisms by which calmodulin recognizes and regulates RyR1 and RyR2 targets, and how arrhythmia-associated variants alter this process, remained incompletely understood.
Arrhythmia-associated calmodulin variants N97I and Q135P impair selectivity for ryanodine receptors by altering kinetic discrimination and allosteric communication, providing mechanistic insights into congenital arrhythmias.
Answers are grounded in this paper and cite their sources.
May inform arrhythmia mechanisms in calmodulinopathies; hypothesis-generating for targeted therapies, pending clinical validation.
Among its many molecular targets, the ubiquitous calcium sensor protein calmodulin (CaM) recognizes and regulates the activity of ryanodine receptors type 1 (RyR1) and 2 (RyR2), mainly expressed in skeletal and cardiac muscle, respectively. Such regulation is essential to achieve controlled contraction of muscle cells. To unravel the molecular mechanisms underlying the target recognition process, we conducted a comprehensive biophysical investigation of the interaction between two calmodulin variants associated with congenital arrhythmia, namely N97I and Q135P, and a highly conserved calmodulin-binding region in RyR1 and RyR2. The structural, thermodynamic, and kinetic properties of protein-peptide interactions were assessed together with an in-depth structural and topological investigation based on molecular dynamics simulations. This integrated approach allowed us to identify amino acids that are crucial in mediating allosteric processes, which enable high selectivity in molecular target recognition. Our results suggest that the ability of calmodulin to discriminate between RyR1 an RyR2 targets depends on kinetic discrimination and robust allosteric communication between Ca2+-binding sites (EF1-EF3 and EF3-EF4 pairs), which is perturbed in both N97I and Q135P arrhythmia-associated variants.
No takes yet. Share an insight, caveat, or question.
Cortivo et al. (2023) studied Congenital arrhythmia. Calmodulin variants N97I and Q135P vs. Wild-type calmodulin was evaluated on Binding affinity and kinetics to RyR1 and RyR2 peptides. Calmodulin variants N97I and Q135P associated with congenital arrhythmia impair the kinetic discrimination and allosteric communication required for selective recognition of ryanodine receptors.
Synapse has enriched 10 related papers. Consider them for comparative context: